Hormonal therapies for new onset and relapsed depression during perimenopause

Maturitas

Volumn 73, Issue 2, 2012, Pages 127-133

  Worsley, Roisin ^a,b   Davis, Susan R ^b   Gavrilidis, Emorfia ^a   Gibbs, Zoe ^a   Lee, Stuart ^a   Burger, Henry ^c   Kulkarni, Jayashri ^a  

^a ALFRED HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

Antidepressants; Depression; Hormone therapy; Oestrogen; Perimenopause; Treatment resistance

Indexed keywords

CLIMACTERIUM; DEPRESSION; ESTROGEN THERAPY; FEMALE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW; RISK FACTOR; TREATMENT FAILURE;

DEPRESSION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; PERIMENOPAUSE; RISK FACTORS; TREATMENT FAILURE;

EID: 84873966757     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2012.06.011     Document Type: Review

References (75)

1. D.J. Brambilla, S.M. McKinlay, and C.B. Johannes Defining the perimenopause for application in epidemiologic investigations American Journal of Epidemiology 140 December (12) 1994 1091 1095
2. M.R. Soules, S. Sherman, E. Parrott, R. Rebar, N. Santoro, and W. Utian Executive summary: Stages of Reproductive Aging Workshop (STRAW) Climacteric 4 December (4) 2001 267 272
3. E.B. Gold The timing of the age at which natural menopause occurs Obstetrics and Gynecology Clinics of North America 38 September (3) 2011 425 440
4. H.G. Burger, G.E. Hale, L. Dennerstein, and D.M. Robertson Cycle and hormone changes during perimenopause: the key role of ovarian function Menopause 15 July-August (4 Pt 1) 2008 603 612
5. G.D. Mishra, and D. Kuh Health symptoms during midlife in relation to menopausal transition: British prospective cohort study BMJ 344 2012 e402
6. P. Bebbington, G. Dunn, R. Jenkins, G. Lewis, T. Brugha, and M. Farrell The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity International Review of Psychiatry 15 February-May (1-2) 2003 74 83
7. L.S. Cohen, C.N. Soares, A.F. Vitonis, M.W. Otto, and B.L. Harlow Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles Archives of General Psychiatry 63 April (4) 2006 385 390
8. E.W. Freeman, M.D. Sammel, H. Lin, and D.B. Nelson Associations of hormones and menopausal status with depressed mood in women with no history of depression Archives of General Psychiatry 63 April (4) 2006 375 382
9. L.W. Maartens, J.A. Knottnerus, and V.J. Pop Menopausal transition and increased depressive symptomatology: a community based prospective study Maturitas 42 July (3) 2002 195 200
10. A. Qaseem, V. Snow, T.D. Denberg, M.A. Forciea, and D.K. Owens Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians Annals of Internal Medicine 149 November (10) 2008 725 733
11. L.L. Altshuler, L.S. Cohen, M.L. Moline, D.A. Kahn, D. Carpenter, and J.P. Docherty Treatment of depression in women: a summary of the expert consensus guidelines Journal of Psychiatric Practice 7 May (3) 2001 185 208
12. G.A. Fava, C. Ruini, and C. Belaise The concept of recovery in major depression Psychological Medicine 37 March (3) 2007 307 317
13. A.A. Nierenberg, and E.C. Wright Evolution of remission as the new standard in the treatment of depression Journal of Clinical Psychiatry 60 Suppl. 22 1999 7 11
14. M. Olfson, S.C. Marcus, M. Tedeschi, and G.J. Wan Continuity of antidepressant treatment for adults with depression in the United States American Journal of Psychiatry 163 January (1) 2006 101 108
15. J.B. Richards, A. Papaioannou, J.D. Adachi, L. Joseph, H.E. Whitson, and J.C. Prior Effect of selective serotonin reuptake inhibitors on the risk of fracture Archives of Internal Medicine 167 January (2) 2007 188 194
16. P. Vestergaard Fracture risks of antidepressants Expert Review of Neurotherapeutics 9 January (1) 2009 137 141
17. F.N. Jacka, J.A. Pasco, M.J. Henry, M.A. Kotowicz, S. Dodd, and G.C. Nicholson Depression and bone mineral density in a community sample of perimenopausal women: Geelong Osteoporosis Study Menopause 12 January-February (1) 2005 88 91
18. G.A. Greendale, M. Sowers, W. Han, M.H. Huang, J.S. Finkelstein, and C.J. Crandall Bone mineral density loss in relation to the final menstrual period in a multi-ethic cohort: results from the study of women's health across the nation (SWAN) Journal of Bone and Mineral Research 27 1 2012 111 118
19. A.L. Montejo, G. Llorca, J.A. Izquierdo, and F. Rico-Villademoros Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction Journal of Clinical Psychiatry 62 Suppl. 3 2001 10 21
20. S.R. Davis, and F. Jane Sex and perimenopause Australian Family Physician 40 May (5) 2011 274 278
21. K.K. Vesco, E.M. Haney, L. Humphrey, R. Fu, and H.D. Nelson Influence of menopause on mood: a systematic review of cohort studies Climacteric 10 December (6) 2007 448 465
22. J.T. Bromberger, and H.M. Kravitz Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN) over 10 years Obstetrics and Gynecology Clinics of North America 38 September (3) 2011 609 625
23. P.J. Schmidt, N. Haq, and D.R. Rubinow A longitudinal evaluation of the relationship between reproductive status and mood in perimenopausal women American Journal of Psychiatry 161 December (12) 2004 2238 2244
24. J.T. Bromberger, and H.M. Kravitz Mood and menopause: findings from the Study of Women's Health Across the Nation (SWAN) over 10 years Obstetrics and Gynecology Clinics of North America 38 September (3) 2004 609 625
25. J.T. Bromberger, H.M. Kravitz, Y.F. Chang, J.M. Cyranowski, C. Brown, and K.A. Matthews Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN) Psychological Medicine 41 September (9) 2011 1879 1888
26. S. Timur, and N.H. Sahin The prevalence of depression symptoms and influencing factors among perimenopausal and postmenopausal women Menopause 17 May-June (3) 2010 545 551
27. S.D. Reed, E.J. Ludman, K.M. Newton, L.C. Grothaus, A.Z. LaCroix, and L. Nekhlyudov Depressive symptoms and menopausal burden in the midlife Maturitas 62 Mar (3) 2009 306 310
28. A.L. Seritan, A.M. Iosif, J.H. Park, D. DeatherageHand, R.L. Sweet, and E.B. Gold Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center Menopause 17 March (2) 2010 410 415
29. C. Callegari, M. Buttarelli, A. Cromi, M. Diurni, F. Salvaggio, and P.F. Bolis Female psychopathologic profile during menopausal transition: a preliminary study Maturitas 56 April (4) 2007 447 451
30. J.T. Bromberger, H.M. Kravitz, K. Matthews, A. Youk, C. Brown, and W. Feng Predictors of first lifetime episodes of major depression in midlife women Psychological Medicine 39 January (1) 2009 55 64
31. E.M. Steinberg, D.R. Rubinow, J.J. Bartko, P.M. Fortinsky, N. Haq, and K. Thompson A cross-sectional evaluation of perimenopausal depression Journal of Clinical Psychiatry 69 June (6) 2008 973 980
32. R.J. Gregory, P.S. Masand, and N.H. Yohai Depression across the reproductive life cycle: correlations between events Primary Care Companion to the Journal of Clinical Psychiatry 2 August (4) 2000 127 129
33. M. Sajatovic, S.H. Friedman, I.N. Schuermeyer, R. Safavi, R.V. Ignacio, and R.W. Hays Menopause knowledge and subjective experience among peri- and postmenopausal women with bipolar disorder, schizophrenia and major depression Journal of Nervous and Mental Disease 194 March (3) 2006 173 178
34. J.L. Payne, P.S. Roy, K. Murphy-Eberenz, M.M. Weismann, K.L. Swartz, and M.G. McInnis Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder Journal of Affective Disorders 99 April (1-3) 2007 221 229
35. S.H. Friedman, M. Sajatovic, I.N. Schuermeyer, R. Safavi, R.W. Hays, and J. West Menopause-related quality of life in chronically mentally ill women International Journal of Psychiatry in Medicine 35 3 2005 259 271
36. M.P. Freeman, K.W. Smith, S.A. Freeman, S.L. McElroy, G.E. Kmetz, and R. Wright The impact of reproductive events on the course of bipolar disorder in women Journal of Clinical Psychiatry 63 April (4) 2002 284 287
37. O. Ozturk, D. Eraslan, H.E. Mete, and S. Ozsener The risk factors and symptomatology of perimenopausal depression Maturitas 55 September (2) 2006 180 186
38. S.G. Kornstein, E.A. Young, A.T. Harvey, S.R. Wisniewski, J.L. Barkin, and M.E. Thase The influence of menopause status and postmenopausal use of hormone therapy on presentation of major depression in women Menopause 17 July (4) 2010 828 839
39. E.W. Freeman, M.D. Sammel, H. Lin, C.R. Gracia, and S. Kapoor Symptoms in the menopausal transition: hormone and behavioral correlates Obstetrics and Gynecology 111 January (1) 2008 127 136
40. J.T. Bromberger, S.F. Assmann, N.E. Avis, M. Schocken, H.M. Kravitz, and A. Cordal Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women American Journal of Epidemiology 158 August (4) 2003 347 356
41. L. Binfa, C. Castelo-Branco, J.E. Blumel, M.J. Cancelo, H. Bonilla, and I. Munoz Influence of psycho-social factors on climacteric symptoms Maturitas 48 August (4) 2004 425 431
42. J.T. Bromberger, K.A. Matthews, L.L. Schott, S. Brockwell, N.E. Avis, and H.M. Kravitz Depressive symptoms during the menopausal transition: the Study of Women's Health Across the Nation (SWAN) Journal of Affective Disorders 103 November (1-3) 2007 267 272
43. M. Richards, D.R. Rubinow, R.C. Daly, and P.J. Schmidt Premenstrual symptoms and perimenopausal depression American Journal of Psychiatry 163 January (1) 2006 133 137
44. M. Flores-Ramos, G. Heinze, and R. Silvestri-Tomassoni Association between depressive symptoms and reproductive variables in a group of perimenopausal women attending a menopause clinic in Mexico City Archives of Women's Mental Health 13 February (1) 2009 99 105
45. E.W. Freeman, M.D. Sammel, H. Lin, C.R. Gracia, G.W. Pien, and D.B. Nelson Symptoms associated with menopausal transition and reproductive hormones in midlife women Obstetrics and Gynecology 110 August (2 Pt 1) 2007 230 240
46. H. Joffe, J.E. Hall, C.N. Soares, J. Hennen, C.J. Reilly, and K. Carlson Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care Menopause 9 November-December (6) 2002 392 398
47. P.J. Schmidt, L. Nieman, M.A. Danaceau, M.B. Tobin, C.A. Roca, and J.H. Murphy Estrogen replacement in perimenopause-related depression: a preliminary report American Journal of Obstetrics and Gynecology 183 August (2) 2000 414 420
48. L.S. Cohen, C.N. Soares, J.R. Poitras, J. Prouty, A.B. Alexander, and J.L. Shifren Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report American Journal of Psychiatry 160 August (8) 2003 1519 1522
49. P.J. Schmidt, J.H. Murphy, N. Haq, M.A. Danaceau, and L. St Clair Basal plasma hormone levels in depressed perimenopausal women Psychoneuroendocrinology 27 November (8) 2002 907 920
50. H.M. Kravitz, I. Janssen, F.E. Lotrich, D.M. Kado, and J.T. Bromberger Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife American Journal of Medicine 119 September (9 Suppl. 1) 2006 S87 S93
51. R.C. Daly, M.A. Danaceau, D.R. Rubinow, and P.J. Schmidt Concordant restoration of ovarian function and mood in perimenopausal depression American Journal of Psychiatry 160 October (10) 2003 1842 1846
52. M.L. Morgan, I.A. Cook, A.J. Rapkin, and A.F. Leuchter Neurophysiologic changes during estrogen augmentation in perimenopausal depression Maturitas 56 January (1) 2007 54 60
53. P.J. Schmidt, and D.R. Rubinow Sex hormones and mood in the perimenopause Annals of the New York Academy of Sciences 1179 October 2009 70 85
54. D. Deecher, T.H. Andree, D. Sloan, and L.E. Schechter From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes Psychoneuroendocrinology 33 January (1) 2008 3 17
55. B. McEwen Estrogen actions throughout the brain Recent Progress in Hormone Research 57 2002 357 384
56. D. Goldberg The aetiology of depression Psychological Medicine 36 October (10) 2006 1341 1347
57. I.R. Cohen, and P.M. Wise Effects of estradiol on the diurnal rhythm of serotonin activity in microdissected brain areas of ovariectomized rats Endocrinology 122 June (6) 1988 2619 2625
58. G. Fink, and B.E. Sumner Oestrogen and mental state Nature 383 6598 1996
59. B.E.H. Sumner, and G. Fink Estrogen increases the density of 5-hydroxytryptamine 2A receptors in cerebral cortex and nucleus accumbens in the female rat The Journal of Steroid Biochemistry and Molecular Biology 54 1-2 1995 15 20
60. T. Matsuda, Y. Nakano, T. Kanda, H. Iwata, and A. Baba Gonadal hormones affect the hypothermia induced by serotonin 1A (5-HT1A) receptor activation Life Sciences 48 17 1991 1627 1632
61. C.N. Soares, J.R. Poitras, and J. Prouty Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause Drugs and Aging 20 2 2003 85 100
62. B.L. Parry Perimenopausal depression American Journal of Psychiatry 165 January (1) 2008 23 27
63. C.N. Soares Depression during the menopausal transition: window of vulnerability or continuum of risk? Menopause 15 March-April (2) 2008 207 209
64. C.N. Soares, O.P. Almeida, H. Joffe, and L.S. Cohen Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial Archives of General Psychiatry 58 June (6) 2001 529 534
65. M.L. Morgan, I.A. Cook, A.J. Rapkin, and A.F. Leuchter Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study Journal of Clinical Psychiatry 66 June (6) 2005 774 780
66. C.N. Soares, J.R. Poitras, J. Prouty, A.B. Alexander, J.L. Shifren, and L.S. Cohen Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms Journal of Clinical Psychiatry 64 April (4) 2003 473 479
67. H. Joffe, C.N. Soares, L.F. Petrillo, A.C. Viguera, B.L. Somley, and J.K. Koch Treatment of depression and menopause-related symptoms with the serotonin-norepinephrine reuptake inhibitor duloxetine Journal of Clinical Psychiatry 68 June (6) 2007 943 950
68. P.J. Schmidt, J.H. Murphy, N. Haq, D.R. Rubinow, and M.A. Danaceau Stressful life events, personal losses, and perimenopause-related depression Archives of Women's Mental Health 7 February (1) 2004 19 26
69. L. Andreen, S. Nyberg, S. Turkmen, G. van Wingen, G. Fernandez, and T. Backstrom Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators Psychoneuroendocrinology 34 September (8) 2009 1121 1132
70. C.N. Soares, H. Arsenio, H. Joffe, B. Bankier, P. Cassano, and L.F. Petrillo Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life Menopause 13 September-October (5) 2006 780 786
71. H.J. Kloosterboer Tibolone: a steroid with a tissue-specific mode of action Journal of Steroid Biochemistry and Molecular Biology 76 January-March (1-5) 2001 231 238
72. A.R. Genazzani, F. Petraglia, F. Facchinetti, A.D. Genazzani, M. Bergamaschi, and A. Grasso Effects of Org OD 14 on pituitary and peripheral beta-endorphin in castrated rats and post-menopausal women Maturitas Suppl. 1 1987 35 48
73. M. Doren, A. Rubig, H.J. Coelingh Bennink, and W. Holzgreve Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy Fertility and Sterility 75 March (3) 2001 554 559
74. F. Cosman, and R. Lindsay Selective estrogen receptor modulators: clinical spectrum Endocrine Reviews 20 June (3) 1999 418 434
75. J. Kulkarni, C. Gurvich, S.J. Lee, H. Gilbert, E. Gavrilidis, and A. de Castella Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia Psychoneuroendocrinology 35 September (8) 2010 1142 1147